Pembrolizumab or placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: An updated analysis of KEYNOTE-859 for patients enrolled in Asia.

CAR-T cell immunotherapy involves harvesting immune-system T cells from a patient and genetically re-engineering them in the lab to recognize targets on the surface of cancer cells when they are ...

Get Instant Summarized Text (Gist) A three-drug cocktail has been identified to enhance CAR-T cell therapy by preserving T-memory stem cells (T SCM), crucial for long-term persistence.The cocktail ...

A study published in Science Advances shares new insights into how two of the most common types of chimeric antigen receptor (CAR) T cells kill cancer. Investigators from Baylor College of Medicine, ...

They affect mainly children and young adults, and are a leading cause of childhood-cancer ... CAR T cells for treating solid cancers in the CNS, and highlights the potential of intracranial cell ...

Like CAR-T cell therapy, in which immune cells called T cells are harvested from the patient and genetically modified to attack cancer cells, this new approach engineers a different type of immune ...

Notably, these data were shared in a presentation from investigators at the 2024 American Society of Hematology Annual Meeting. CAR T-cell therapy: a type of cancer immunotherapy where a patient's own ...

only for the cancer to return. After years of medication, he turned to CAR T-cell therapy, a relatively new treatment that has shown promising results. They took out my T-cells and they sent them ...

CAR-T cell therapy is an individualised treatment for patients, currently licensed for people living with some types of blood cancer. More specifically, CAR-T cell therapy engineers a patient’s ...

Amidst the increasing incidence of blood cancer cases, Qartemi—a pioneering CAR-T cell therapy from Immuneel Therapeutics—stands as a lifeline, representing the need for advanced treatment in ...

NEW DELHI: India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects the lymphatic system, has been launched in the country ...